Literature DB >> 24246762

HIV accessory proteins versus host restriction factors.

Klaus Strebel1.   

Abstract

Primate immunodeficiency viruses, including HIV-1, are characterized by the presence of accessory genes such as vif, vpr, vpx, vpu, and nef. Current knowledge indicates that none of the primate lentiviral accessory proteins has enzymatic activity. Instead, these proteins interact with cellular ligands to either act as adapter molecules to redirect the normal function of host factors for virus-specific purposes or to inhibit a normal host function by mediating degradation or causing intracellular mislocalization/sequestration of the factors involved. This review aims at providing an update of our current understanding of how Vif, Vpu, and Vpx control the cellular restriction factors APOBEC3G, BST-2, and SAMHD1, respectively. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24246762      PMCID: PMC3855913          DOI: 10.1016/j.coviro.2013.08.004

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  80 in total

Review 1.  Immune response to HIV.

Authors:  Matthieu Perreau; Yves Levy; Giuseppe Pantaleo
Journal:  Curr Opin HIV AIDS       Date:  2013-07       Impact factor: 4.283

2.  The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses.

Authors:  S Bour; K Strebel
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

3.  Some human immunodeficiency virus type 1 Vpu proteins are able to antagonize macaque BST-2 in vitro and in vivo: Vpu-negative simian-human immunodeficiency viruses are attenuated in vivo.

Authors:  Masashi Shingai; Takeshi Yoshida; Malcolm A Martin; Klaus Strebel
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

4.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

5.  Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx.

Authors:  Thomas Gramberg; Nicole Sunseri; Nathaniel R Landau
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

6.  Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.

Authors:  Daniel Sauter; Michael Schindler; Anke Specht; Wilmina N Landford; Jan Münch; Kyeong-Ae Kim; Jörg Votteler; Ulrich Schubert; Frederic Bibollet-Ruche; Brandon F Keele; Jun Takehisa; Yudelca Ogando; Christina Ochsenbauer; John C Kappes; Ahidjo Ayouba; Martine Peeters; Gerald H Learn; George Shaw; Paul M Sharp; Paul Bieniasz; Beatrice H Hahn; Theodora Hatziioannou; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2009-11-19       Impact factor: 21.023

7.  Human immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variant.

Authors:  Sandrine Opi; Sandra Kao; Ritu Goila-Gaur; Mohammad A Khan; Eri Miyagi; Hiroaki Takeuchi; Klaus Strebel
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

8.  Cytidine deamination induced HIV-1 drug resistance.

Authors:  Lubbertus C F Mulder; Ariana Harari; Viviana Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-07       Impact factor: 11.205

9.  Simian immunodeficiency virus of African green monkeys is apathogenic in the newborn natural host.

Authors:  B Beer; J Denner; C R Brown; S Norley; J zur Megede; C Coulibaly; R Plesker; S Holzammer; M Baier; V M Hirsch; R Kurth
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-07-01

Review 10.  HIV-1 Vif, APOBEC, and intrinsic immunity.

Authors:  Ritu Goila-Gaur; Klaus Strebel
Journal:  Retrovirology       Date:  2008-06-24       Impact factor: 4.602

View more
  56 in total

1.  Vpr Targets TET2 for Degradation by CRL4VprBP E3 Ligase to Sustain IL-6 Expression and Enhance HIV-1 Replication.

Authors:  Lei Lv; Qi Wang; Yanping Xu; Li-Chung Tsao; Tadashi Nakagawa; Haitao Guo; Lishan Su; Yue Xiong
Journal:  Mol Cell       Date:  2018-06-07       Impact factor: 17.970

2.  Structural Basis of Clade-specific Engagement of SAMHD1 (Sterile α Motif and Histidine/Aspartate-containing Protein 1) Restriction Factors by Lentiviral Viral Protein X (Vpx) Virulence Factors.

Authors:  Ying Wu; Leonardus M I Koharudin; Jennifer Mehrens; Maria DeLucia; Chang-Hyeok Byeon; In-Ja L Byeon; Guillermo Calero; Jinwoo Ahn; Angela M Gronenborn
Journal:  J Biol Chem       Date:  2015-06-04       Impact factor: 5.157

3.  Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells.

Authors:  Marie Lambelé; Herwig Koppensteiner; Menelaos Symeonides; Nathan H Roy; Jany Chan; Michael Schindler; Markus Thali
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

Review 4.  APOBECs and virus restriction.

Authors:  Reuben S Harris; Jaquelin P Dudley
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

5.  Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.

Authors:  Caitlin M Miller; Hisashi Akiyama; Luis M Agosto; Ann Emery; Chelsea R Ettinger; Ronald I Swanstrom; Andrew J Henderson; Suryaram Gummuluru
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

6.  Modeling the evolution of SIV sooty mangabey progenitor virus towards HIV-2 using humanized mice.

Authors:  Kimberly Schmitt; Dipu Mohan Kumar; James Curlin; Leila Remling-Mulder; Mark Stenglein; Shelby O'Connor; Preston Marx; Ramesh Akkina
Journal:  Virology       Date:  2017-07-24       Impact factor: 3.616

7.  Large-Scale Arrayed Analysis of Protein Degradation Reveals Cellular Targets for HIV-1 Vpu.

Authors:  Prashant Jain; Guney Boso; Simon Langer; Stephen Soonthornvacharin; Paul D De Jesus; Quy Nguyen; Kevin C Olivieri; Alex J Portillo; Sunnie M Yoh; Lars Pache; Sumit K Chanda
Journal:  Cell Rep       Date:  2018-02-27       Impact factor: 9.423

8.  Autophagy restricts HIV-1 infection by selectively degrading Tat in CD4+ T lymphocytes.

Authors:  Sophie Sagnier; Coralie F Daussy; Sophie Borel; Véronique Robert-Hebmann; Mathias Faure; Fabien P Blanchet; Bruno Beaumelle; Martine Biard-Piechaczyk; Lucile Espert
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

9.  The DDB1-DCAF1-Vpr-UNG2 crystal structure reveals how HIV-1 Vpr steers human UNG2 toward destruction.

Authors:  Ying Wu; Xiaohong Zhou; Christopher O Barnes; Maria DeLucia; Aina E Cohen; Angela M Gronenborn; Jinwoo Ahn; Guillermo Calero
Journal:  Nat Struct Mol Biol       Date:  2016-08-29       Impact factor: 15.369

10.  Non-POU Domain-Containing Octamer-Binding Protein Negatively Regulates HIV-1 Infection in CD4(+) T Cells.

Authors:  Corine St Gelais; Jonathan Roger; Li Wu
Journal:  AIDS Res Hum Retroviruses       Date:  2015-04-06       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.